COVID-19

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.

Principal Investigator

The Role of Telehealth in COVID-19 Response

Description

This research, using data from the country’s largest telehealth provider and claims from a large commercial payer, will examine the impact of the COVID-19 pandemic and telehealth on utilization, outcomes, disparities, and public health surveillance.

Grant Number
R01 HS028127
Principal Investigator(s)

Evaluating and Enhancing Health Information Technology for COVID-19 Response Workflow in a Specialized COVID-19 Hospital in a Medically Underserved Community

Description

This research will study how a safety-net hospital responds to a pandemic, specifically COVID-19, to identify how information needs are met and how decisions are made and communicated to other individuals internal and external to the institution.

Grant Number
R01 HS028220
Principal Investigator(s)

Implementation of a Novel Multi-Platform Evidence-Based Clinical Decision Support System

Description

This research will demonstrate the use of standards, including SMART on FHIR, combined with service-oriented architecture to bring vendor-agnostic clinical decision support (CDS) tools into commercial electronic health records, and provide evidence for how to implement validated CDS for important clinical domains, pulmonary, and venous thromboembolism, including for patients with COVID-19.

Grant Number
R18 HS026196
Principal Investigator(s)

Improving Patient Safety and Clinician Cognitive Support Through eMAR Redesign

Description

This study will create an innovative electronic medication administration record prototype and a medication administration workflow risk assessment to improve the medication administration process and the usability and safety of the electronic medication administration records in response to challenges from COVID-19.

Grant Number
R01 HS025136
Principal Investigator(s)